OBJECTIVE: Cerebral hemorrhage can cause hemorrhagic stroke, leading to severe brain damage. MiRNA-155 is closely related to the development of stroke. However, the regulatory mechanism of miRNA-155 during cerebral ischemia has not yet been elucidated.
MATERIALS AND METHODS: SD rats were separated to sham operation group, model group, miRNA-155 inhibitor group and miRNA-155 agonist group followed by analysis of neural function, miRNA-155 and pacemaker ion channel hyperpolarization-activated, cyclic nucleotide-gated (HCN) expression by Real Time PCR. Meanwhile, Caspase 3 activity, glutamic acid (Glu) and γ-aminobutyric acid (GABA) content were also measured along with analysis of IL-6 and IL-1β secretion by ELISA as well as reactive oxygen species (ROS) content and superoxide dismutase (SOD) activity.
RESULTS: Compared to sham operation group, model group presented significantly elevated miRNA-155 level and Longa score, decreased HCN expression, elevated Caspase 3 activity and Glu content, and reduced GABA and SOD activity. Meanwhile, model group also had elevated IL-6 and IL-1β secretion, and ROS content (p<0.05). The miRNA-155 agonist group further exacerbated these changes (p<0.01). The miRNA-155 inhibitor group could inhibit miRNA-155 expression and significantly reverse the above pathological changes (p<0.05).
CONCLUSIONS: miRNA-155 is increased in cerebral ischemia. Regulation of miRNA-155 expression can target neuronal pacing ion channel HCN channel to regulate the release of amino acid transmitters, thereby alleviating the progress of cerebral ischemia.Free PDF Download
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License
To cite this article
J.-J. Zhao, Y.-H. Zang, Y. Liu, Y.-J. Liu, J.-N. Wang
Interaction between miRNA-155 targeting neuronal pacemaker ion channels and release of amino acid transmitters during cerebral ischemia
Eur Rev Med Pharmacol Sci
Vol. 25 - N. 7